Summary
Flomoxef and cefazolin had nearly the same activity against staphylococci, which was stronger than that of other cephalosporins. AgainstStreptococcus pyogenes, Streptococcus agalactiae andStreptococcus pneumoniae, cefotaxime and cefazolin were more active than flomoxef, but the other cephamycins were less active than flomoxef. In comparison to the other cephalosporins, latamoxef and flomoxef had higher activity againstBranhamella catarrhalis, whereas cefotaxime, latamoxef and cefotetan were more active againstHaemophilus influenzae. Flomoxef was the only drug exhibiting activity againstClostridium difficile. The activity of flomoxef and latamoxef againstBacteroides fragilis was stronger than that of the other cephalosporins, butBacteroides bivius was resistant to each of these antibiotics.
Zusammenfassung
Flomoxef und Cefazolin hatten gegen Staphylokokken ungefähr die gleiche Wirksamkeit, während die anderen Cephalosporine schwächer wirkten. GegenStreptococcus pyogenes, Streptococcus agalactiae undStreptococcus pneumoniae waren Cefotaxim und Cefazolin stärker wirksam als Flomoxef, jedoch war Flomoxef den anderen Cephamycinen überlegen. Im Vergleich zu den anderen Cephalosporinen waren Latamoxef und Flomoxef stärker wirksam gegenBranhamella catarrhalis, während Cefotaxim, Latamoxef und Cefotetan gegenHaemophilus influenzae aktiver waren. Flomoxef war das einzig wirksame Mittel gegenClostridium difficile. GegenBacteroides fragilis wirkten Flomoxef und Latamoxef am besten (nurBacteroides bivius war völlig resistent).
Similar content being viewed by others
Literature
Tsuji, T., Satoh, M., Narisada, M., Hamashima, Y., Yoshida, T. Synthesis and antibacterial activity of 6315-S, a new member of the oxacephem antibiotic. J. Antibiot. 38 (1985) 466–476.
Suzuki, K., Takanashi, K. 6315-S (flomoxef) in urological infections. Chemotherapy 35 (1987) 1016–1031.
Kuriyama, M., Takahashi, Y. 6315-S (flomoxef), a newly synthesized oxacephem, in urology. Chemotherapy 35 (1987) 1032–1048.
Neu, H. C., Chin, N-X. In vitro activity and β-lactamase stability of a new difluoro oxacephem, 6315-S. Antimicrob. Agents Chemother. 30 (1986) 638–644.
Sagawa, T., Mure, K. 6315-S (flomoxef) in obstetrics and gynecology. Chemotherapy 30 (1987) 1164–1171.
Matsuda, S., Suzuki, M. 6315-S (flomoxef) in obstetrics and gynecology. Chemotherapy 35 (1987) 1189–1195.
Goto, T., Shimada, T. 6315-S (flomoxef) in urinary tract infections. Chemotherapy 35 (1987) 1130–1137.
Matsumoto, T., Kitada, S. Clinical experience with 6315-S (flomoxef) in urinary tract infection. Chemotherapy 35 (1987) 1102–1120.
Sakai, K., Fujimoto, M. A comparative study on the efficacy of 6315-S (flomoxef) and cefotiam. Chemotherapy 35 (1987) 912–942.
Werner, H. Inhibitory activity of cefotetan and other β-lactams against anaerobes. J. Antimicrob. Chemother. 11 (1983) 107–115.
Fujii, A., Nakanishi, T. 6315-S (flomoxef) in urinary tract infection. Chemotherapy 35 (1987) 1059–1069.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, C., Simon, M. & Plieth, C. In vitro activity of flomoxef in comparison to other cephalosporins. Infection 16, 131–134 (1988). https://doi.org/10.1007/BF01644322
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644322